# Liposomal Bupivacaine for Pain Control Following Anterior Cruciate Ligament Reconstruction

> **NCT02189317** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 50 (actual)

## Conditions studied

- Anterior Cruciate Ligament Rupture

## Interventions

- **DRUG:** Exparel

## Key facts

- **NCT ID:** NCT02189317
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02189317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02189317, "Liposomal Bupivacaine for Pain Control Following Anterior Cruciate Ligament Reconstruction". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02189317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*